COMP <GO>
EMBC vs UNH // RSI-14 & 200D SMA MOMENTUM
Embecta Corp. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: EMBC 6
— UNH 4
▲ RSI-14 & 200D SMA MOMENTUM LEADER: UNH
LAST: $6.56 (+1.55%) • MKT CAP: $371.7M
rsi-technicals
52.2
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
rsi-technicals
59.2
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMBC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMBC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.60% | 88.57% | -25.97 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 35.50% | 11.47% | +24.03 | EMBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | 16.4x | -10.35 | EMBC | /valuation <GO> |
| Free Cash Flow Yield | — | 6.48% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 22.40% | 4.82% | +17.58 | EMBC | /operating-margins <GO> |
| Net Profit Margin | 8.80% | 3.14% | +5.66 | EMBC | /net-margins <GO> |
| Revenue Growth (YoY) | -3.80% | 6.46% | -10.26 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 9.42% | 2.28% | +7.14 | EMBC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.12 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 52.2 | 59.2 | -7.01 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 3.6x | 17.1x | -13.49 | EMBC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $371.7M | $368.83B | -$368.46B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMBC REV | UNH REV | EMBC GROSS % | UNH GROSS % | EMBC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.08B | $447.57B | 62.6% | 88.7% | $182.4M | $16.07B |
| FY 2024 | $1.12B | $400.28B | 65.5% | 88.3% | $19.9M | $20.70B |
| FY 2023 | $1.12B | $371.62B | — | 89.6% | $67.7M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMBC // BETA —
UNH // BETA 0.33